PEPPER Trial
Cross-source consensus on PEPPER Trial from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Other
Other
Highlighted claims
- The PEPPER trial is a Belgian multicentre, pragmatic, open-label randomised clinical trial in primary care. — Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients
- The trial is designed to identify the most effective strategy for stopping chronic PPI use in adults without a firm long-term indication. — Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients
- PEPPER plans to randomise 609 patients across three arms. — Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients
- The trial estimates that 745 patients must be included because some high-dose patients may not reach randomisation after down-titration. — Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients
- The PEPPER trial had recruited 82 Belgian GPs as principal investigators at the time of reporting. — Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients